rampart-trial.org valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /media/ Disallow: /css/ Disallow: /scripts/ Disallow: | ||
Meta Tags
| Title | RAMPART |
| Description | Latest RAMPART -Renal Adjuvant MultiPle Arm Randomised Trial. RAMPART is an international investigator-led phase lll multi-arm multi-stage multi-centrerandomised controlled platform trial of adjuvant therapy in patients with resected primary renal cell |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 144.82.251.120 |
| Location | United Kingdom |
Related Websites
| Site | Rank |
More to Explore
rampart-trial.org Valuation
|
US$1,066,442
Last updated: 2023-05-16 11:06:04
rampart-trial.org has Semrush global rank of 9,924,878. rampart-trial.org has an estimated worth of US$ 1,066,442, based on its estimated Ads revenue. rampart-trial.org receives approximately 123,051 unique visitors each day. Its web server is located in United Kingdom, with IP address 144.82.251.120. According to SiteAdvisor, rampart-trial.org is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,066,442 |
| Daily Ads Revenue | US$985 |
| Monthly Ads Revenue | US$29,533 |
| Yearly Ads Revenue | US$354,387 |
| Daily Unique Visitors | 8,204 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| rampart-trial.org. | A | 299 | IP: 144.82.251.120 |
| rampart-trial.org. | NS | 300 | NS Record: ns1.meganameservers.eu. |
| rampart-trial.org. | NS | 300 | NS Record: ns3.meganameservers.eu. |
| rampart-trial.org. | NS | 300 | NS Record: ns2.meganameservers.eu. |
| rampart-trial.org. | MX | 300 | MX Record: 110 mx3c51.megamailservers.eu. |
| rampart-trial.org. | MX | 300 | MX Record: 10 mx1c51.megamailservers.eu. |
| rampart-trial.org. | MX | 300 | MX Record: 100 mx2c51.megamailservers.eu. |
HtmlToTextCheckTime:2023-05-16 11:06:04
| RAMPART Menu Search the site Sitemap Members Login Welcome to the Rampart website. To help tailor your experience, please select Patient/Public or Health Professional . Patient / Public Health Professional Latest News 3rd May 2023 RAMPART CLOSURE TO RECRUITMENT Following discussions between the TMG and our pharmaceutical partners, AstraZeneca, we are writing to notify you that RAMPART will be closing to recruitment on Friday 30 th June 2023 . Patients already participating in RAMPART and those who are randomised between now and the end of June will continue their allocated treatment/Follow-up as per the protocol. There are two documents linked below that provide details about this decision and what this means for your sites moving forward. These documents are: The RAMPART Trial Management team wish to thank you all for your continued work and support on RAMPART and we look forward to continuing to work with you in the coming years. Links: RAMPART Closure letter , FAQs 29th March 2023 |
rampart-trial.org Whois Information
Domain Name: RAMPART-TRIAL.ORG Registry Domain ID: D402200000001727073-LROR Registrar WHOIS Server: whois.ascio.com Registrar URL: http://www.ascio.com Updated Date: 2022-01-07T10:11:04Z Creation Date: 2017-03-06T14:31:42Z Registry Expiry Date: 2023-03-06T14:31:42Z Registrar: Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA Registrar IANA ID: 106 Registrar Abuse Contact Email: abuse@ascio.com Registrar Abuse Contact Phone: +1.4165350123 Domain Status: ok https://icann.org/epp#ok Registrant Country: GB Name Server: NS1.MEGANAMESERVERS.EU Name Server: NS2.MEGANAMESERVERS.EU Name Server: NS3.MEGANAMESERVERS.EU DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form https://www.icann.org/wicf/) >>> Last update of WHOIS database: 2022-01-23T11:17:31Z <<< |